Comparative Effectiveness of Umeclidinium/Vilanterol versus Inhaled Corticosteroid/Long-Acting β 2 -Agonist in Patients with Chronic Obstructive Pulmonary Disease in a Primary Care Setting in England.
Alexandrosz CziraGema RequenaVictoria L BanksRobert P WoodTheo TrittonCatherine M CastilloJie YeapRosie A C WildChris ComptonKieran J RothnieFelix J F HerthJennifer Kathleen QuintAfisi S IsmailaPublished in: International journal of chronic obstructive pulmonary disease (2023)
At 12 months post-treatment initiation, once-daily UMEC/VI was superior to twice-daily ICS/LABA in medication adherence among patients with COPD without exacerbations in the previous year, newly initiating dual maintenance therapy in England. The finding was consistent at 6, 18, and 24 months.